Jennel Carreras, MD
Plastic Surgery · Ocala, FLNPI 1376834564
Payments from drug & device makers
Across 156 payments — averaging $25.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pinnacle, Inc$829
- Polarityte, Inc.$95
- Access Pro Medical, LLC$92
- Kerecis Limited$83
- Integra Lifesciences Corporation$77
- plus $402 from 13 others
What the payments were for
- Food & beverage$3,14279%
- Education$81921%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 128 | $2,382 |
| Pinnacle, Inc | 2 | $829 |
| Polarityte, Inc. | 1 | $95 |
| Access Pro Medical, LLC | 2 | $92 |
| Kerecis Limited | 2 | $83 |
| Integra Lifesciences Corporation | 3 | $77 |
| Motiva USA, LLC | 1 | $74 |
| Mentor Worldwide LLC | 2 | $73 |
| Apyx Medical Corporation | 1 | $56 |
| Smith+Nephew | 3 | $40 |
| TELA Bio, Inc. | 3 | $34 |
| Sientra, Inc. | 1 | $19 |
| Stryker | 1 | $17 |
| BD | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Innovation Technologies Inc | 1 | $15 |
| Davol Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,961 in reported general payments places this provider in the 60th percentile of 456 plastic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $923 |
| Cephalexin | 105 | $887 |
| Ondansetron OdtOndansetron | 58 | $636 |
| Ondansetron Hcl | 37 | $314 |
| Montelukast Sodium | 46 | $186 |
| Scopolamine | 13 | $158 |
| Clindamycin Hcl | 22 | $127 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $114 |
| Ciprofloxacin Hcl | 12 | $70 |
| Tramadol Hcl | 18 | $53 |
| Alprazolam | 20 | $13 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Ocala
- Robert RehnkeSt Petersburg$6.1M
- Enrique HanaberghAventura$2.1M
- Anthony DardanoBoca Raton$586K
- Devinder SinghMiami$407K
- Brad HermanSouth Miami$293K
- Melanie Aya-AyTampa$283K
- Gloria YeeMiami$268K
- Daniel KappWest Palm Beach$252K
- Essie Kueberuwa YatesWeston$197K
- Michael MirmaneshPinellas Park$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.